Lori Lyons-Williams

President and CEO, Abdera Therapeutics.

[Lori Lyons-Williams @LoLyonsWilliams]

Thank you to our employees, partners and investors....announcing Abdera Therapeutics! Volume up! #abdera #teamabdera

[Abdera Therapeutics @AbderaTx]

We’re excited to announce today $142M in financing that enables us to design and develop tunable, antibody-based radiopharmaceuticals for #cancer. Learn more here: https://t.co/3zaaOY1yRr

[Lori Lyons-Williams @LoLyonsWilliams]

@SFBIZronleuty Looks like a good call of the spread with two minutes left…

[Lori Lyons-Williams @LoLyonsWilliams]

@jaketapper 🥺🙏🏼

[Lori Lyons-Williams @LoLyonsWilliams]

@matthewherper 🥺🙏🏼

[TAYLA @ponar15]

no swiftie should have less than 10k followers.

Like/rt and comment “❤️‍🔥" follow everyone who likes your comment.

[Lori Lyons-Williams @LoLyonsWilliams]

@ponar15 ❤️‍🔥❤️‍🔥

[Abdera Therapeutics @AbderaTx]

Next week at the 4th #TRPSummit2025, Abdera CTO Kawa Chiu takes the stage to chair Day 1 & weigh in on two panels, covering real-world evidence in RLT trial design & the future of talent in radiopharma. Kawa’s perspective is shaped by years at the forefront of targeted #radiotherapeutics. We're excited to see her help lead the conversation in San Diego.

[Abdera Therapeutics @AbderaTx]

The Abdera team was proud to attend #AACR25, where we presented a Trial-in-Progress for our Phase 1 study of ABD-147 and unveiled our second lead program, ABD-320. We're energized by the progress across #oncology and remain committed to advancing novel radiopharmaceutical therapies for patients.

[Abdera Therapeutics @AbderaTx]

Heading to #JPM25? Abdera President & CEO Lori Lyons-Williams will present on Mon, Jan 13 at 10:30 a.m. PR, highlighting the company’s progress & key milestones, including the recent initiation of our first-in-human Phase 1 clinical trial for ABD-147 & preclinical data for ABD-320. Learn more here: https://t.co/99FN7Ez28o

[Abdera Therapeutics @AbderaTx]

Employees like Gabriel are at the heart of what we are set out to accomplish at Abdera. Our team is filled with curious and creative minds who come together everyday to bring new hope to those facing devastating diagnoses. To join our team, visit https://t.co/n3y0OgoePH.

[Abdera Therapeutics @AbderaTx]

We loved seeing some of the Abdera team hit the pavement running at the JP Morgan Corporate Challenge in San Francisco! Cheers to a great event, supporting the community, and moving together toward a healthier future. #JPMCC

[Abdera Therapeutics @AbderaTx]

We’re committed to building a team that’s focused on offering new hope to families facing devastating diseases. It’s passionate leaders like Kimberly that continue to drive our mission to transform how #cancer is treated. Learn more and join our team at https://t.co/n3y0OgoePH.

[Abdera Therapeutics @AbderaTx]

We're excited to announce the Orphan Drug Designation granted by the @ US_FDA to ABD-147 for the treatment of neuroendocrine carcinoma. Learn more about this next-generation precision #radiopharmaceutical therapy here: https://t.co/oinUFXZbIP

[Lori Lyons-Williams @LoLyonsWilliams]

@MaayanJaffe @jaketapper 🙏🏼

[Abdera Therapeutics @AbderaTx]

We’re honored to be recognized as a top innovator in #biotech on @FierceBiotech #Fierce15 list. We're in the pursuit to develop better, optimized therapies for people living with #cancer and we couldn't be more proud of what our team is accomplishing!
https://t.co/MAJ1U8vrKe

[Lori Lyons-Williams @LoLyonsWilliams]

Today is a big day at @AbderaTx!

[Abdera Therapeutics @AbderaTx]

We're excited to announce the clearance of our IND by the @US_FDA for ABD-147 for the treatment of small cell #lungcancer. Learn more about this next-generation precision #radiopharmaceutical therapy here: https://t.co/9KYxx5uoV8

[Peter Wehner @Peter_Wehner]

This is an extraordinary tribute by @davidfrum to his daughter Miranda, and to the dog she loved. It's beautiful and moving. Such grief, and such loving memories. Just be prepared to weep as you read it. You won't forget it, or Miranda.
https://t.co/VtwU9unEdT

[Fierce Life Sciences Events @LifeSciEvents]

💡JPM 2024 Featured Session with Kristin Bedard- @LoxoLillyOnc, @SabatosPeyton-@LarkspurBio, Daejin Abidoye-@abbvie, David Weinstock -@Merck, and @LoLyonsWilliams-@AbderaTx
Advanced Rate is available through Dec 22nd! Here: https://t.co/UtODpkkhRg
#FierceJPMWeek #JPMWeek

[Lori Lyons-Williams @LoLyonsWilliams]

Living for these vibes! 🎄🥳
Friendsmas 2023 brought out all the festive feels, making it the highlight of my year. Relive the magic with me! ☃️✨
#VeryMerry
#LaughterLoveEndlessCheer
#AlITheFeels #Friendsmas

[1AB @1ABMedia]

We're kicking off our own cruel summer with a little fun by uncovering biotech's secret Swifties! Tell us - what Taylor Swift song will you have on your playlist this holiday weekend?

[Lori Lyons-Williams @LoLyonsWilliams]

Go, Team Abdera!
https://t.co/Fcq1gPDGu2